首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of cardiovascular medicine

缩写:J CARDIOVASC MED

ISSN:1558-2027

e-ISSN:1558-2035

IF/分区:2.6/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引2914条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Carlo Alberto Caruzzo,Sarina Leupp Simone Sarzilla,Antonio Landi et al. Carlo Alberto Caruzzo et al.
Background and aims: Pulmonary embolism (PE) is a potentially life-threatening condition requiring timely intervention. This study sought to investigate the short-term outcomes and complications of pharmacomechanical inte...
Luigi Spadafora,Marco Bernardi,Giuseppe Biondi-Zoccai et al. Luigi Spadafora et al.
Background: The GRACE score is a well established tool for predicting mortality outcomes in patients with myocardial infarction (MI). However, its prognostic role and interaction with revascularization strategies in older...
Laura De Michieli,Giacomo Tini,Alessia Argirò et al. Laura De Michieli et al.
Background: Patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) often have cardiovascular comorbidities, including acute coronary syndrome (ACS) and coronary artery disease (CAD). ...
Xiaofei Zhang,Kexin Zhang,Jinyan Chen et al. Xiaofei Zhang et al.
Background: Ischemic heart disease (IHD) remains a leading cause of illness and death worldwide, posing a significant global health challenge. This study aims to examine the global impact of IHD over the past three decade...
Sofia Sammartino,Giulia Laterra,Francesco Saia et al. Sofia Sammartino et al.
Background: Despite device improvements for transcatheter aortic valve replacement (TAVR) and increased operator expertise, unfavorable aortic root anatomy might subtend worse procedural and clinical outcomes. The aim of ...
Marco Biasin,Maria Stratinaki,Nicolò Cordioli et al. Marco Biasin et al.
Aims: Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated cardiovascular benefit in patients with type 2 diabetes mellitus (T2DM) and established atherosclerotic disease. Its role in the immediate po...